← Current compounder rows

Current NDC auxiliary source row compounder:1013

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
71266-6487
Product Ndc
71266-6487
Product Ndc Digits
712666487
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
Omnipaque (Iohexol) 240
Proprietary Name Suffix
[empty]
Nonproprietary Name
Iohexol
Dosage Form Name
INJECTION
Route Name
INTRATHECAL; INTRAVENOUS
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
Establishment Name
Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories
Establishment Fei
[empty]
Substance Name
IOHEXOL
Active Ingredients Info
240 mg/1 mL
History Active Ingredients Raw
IOHEXOL
History Active Ingredients Info Raw
240 mg/1 mL
History Dosage Raw
INJECTION
Dea Schedule
[empty]
Package Ndc Raw
71266-6487-5
Package Ndc
71266-6487-5
Package Ndc Digits
7126664875
Package Ndc11
71266648705
Package Description
5 mL in 1 VIAL (71266-6487-5)
Reporting Period Raw
2025-2
Reporting Period
2025-2
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:1013
Source Row Number
1013
Source Row Hash
4bd66bd1fb948050eed91749dea35d8ec49ea03f855f93017a4b0ed454afc46e
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRATHECAL; INTRAVENOUS",
    "PRODUCTNDC": "71266-6487",
    "DEASCHEDULE": "",
    "LABELERNAME": "Fagron Compounding Services LLC dba Fagron Sterile Services LLC dba JCB Laboratories",
    "SUBSTANCENAME": "IOHEXOL",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "71266-6487-5",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Omnipaque (Iohexol) 240",
    "REPORTINGPERIOD": "2025-2",
    "NONPROPRIETARYNAME": "Iohexol",
    "PACKAGEDESCRIPTION": "5 mL in 1 VIAL (71266-6487-5) ",
    "ACTIVEINGREDIENTSINFO": "240 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:1013
Source Row Number
1013
Status Scope
package
Lookup Ndc
71266-6487-5
Lookup Ndc Digits
7126664875
Product Ndc
71266-6487
Product Ndc Digits
712666487
Package Ndc
71266-6487-5
Package Ndc Digits
7126664875
Package Ndc11
71266648705
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2025-2
Reporting Period
2025-2
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
4bd66bd1fb948050eed91749dea35d8ec49ea03f855f93017a4b0ed454afc46e
Import Run Id
20261119T172627Z
Loaded At
2026-11-19 17:42:45